7-76304094-C-T
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PP5_Very_Strong
The NM_001540.5(HSPB1):c.539C>T(p.Thr180Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,474 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T180P) has been classified as Uncertain significance.
Frequency
Consequence
NM_001540.5 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease axonal type 2FInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Illumina, Labcorp Genetics (formerly Invitae)
- neuronopathy, distal hereditary motor, type 2BInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- distal hereditary motor neuropathy type 2Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461474Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 727000 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease axonal type 2F Pathogenic:2
PM2_Supporting: variant is absent from gnomAD v4 (adequate coverage >20X confirmed). PP3 Not Met: REVEL score is 0.61. PM6 Met: 1 point awarded for 4 assumed de novo observations of the variant in probands with phenotype consistent with gene but not highly specific and high genetic heterogeneity (PMID 27862672, 26989944, 28144995, 20870250). PP1 Not Met: 1 informative meiosis in 2 different families (PMID 33381078, 22176143). PS4_Moderate: variant found in 6 unrelated probands with consistent phenotype for disorder (PMID 35330153, 26989944, 31832804, 33381078, 22176143). PS3_Supporting: functional studies provide supportive evidence that this variant has a damaging effect on the gene or gene product (PMID 25220807). Sequencing funded by the International Centre for Genomic Medicine in Neuromuscular Diseases (ICGNMD): https://www.ucl.ac.uk/genomic-medicine-neuromuscular-diseases/. -
This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 180 of the HSPB1 protein (p.Thr180Ile). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant Charcot-Marie-Tooth disease type 2 or distal hereditary motor neuropathy (PMID: 20870250, 22176143, 26989944, 27862672, 28144995). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 447531). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on HSPB1 protein function. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
- -
Charcot-Marie-Tooth disease Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at